162 related articles for article (PubMed ID: 30904670)
1. Poloxamer 188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson's disease.
Dong H; Qin Y; Huang Y; Ji D; Wu F
Neurochem Int; 2019 Jun; 126():178-186. PubMed ID: 30904670
[TBL] [Abstract][Full Text] [Related]
2. Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease.
Ding W; Lin H; Hong X; Ji D; Wu F
Toxicology; 2020 Apr; 436():152437. PubMed ID: 32169474
[TBL] [Abstract][Full Text] [Related]
3. TP53-induced glycolysis and apoptosis regulator (TIGAR) ameliorates lysosomal damage in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-mediated mouse model of Parkinson's disease.
Ge J; Lin H; Yang J; Li Q; Zhou J; Qin Z; Wu F
Toxicol Lett; 2021 Mar; 339():60-69. PubMed ID: 33359019
[TBL] [Abstract][Full Text] [Related]
4. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
[TBL] [Abstract][Full Text] [Related]
6. MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1.
Wang R; Yang Y; Wang H; He Y; Li C
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):372-382. PubMed ID: 31732967
[TBL] [Abstract][Full Text] [Related]
7. Association of increase in Serping1 level with dopaminergic cell reduction in an MPTP-induced Parkinson's disease mouse model.
Seo MH; Yeo S
Brain Res Bull; 2020 Sep; 162():67-72. PubMed ID: 32485229
[TBL] [Abstract][Full Text] [Related]
8. The Involvement of Progranulin for α-Synuclein Reduction through Autolysosome Formation.
Fujimori H; Ohba T; Nakamura S; Shimazawa M; Hara H
Biol Pharm Bull; 2023; 46(8):1032-1040. PubMed ID: 37532554
[TBL] [Abstract][Full Text] [Related]
9. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
[TBL] [Abstract][Full Text] [Related]
10. Mild MPP
Miyara M; Kotake Y; Tokunaga W; Sanoh S; Ohta S
J Neurochem; 2016 Oct; 139(2):294-308. PubMed ID: 27309572
[TBL] [Abstract][Full Text] [Related]
11. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
[TBL] [Abstract][Full Text] [Related]
12. Cdk5/p25 specific inhibitory peptide TFP5 rescues the loss of dopaminergic neurons in a sub-acute MPTP induced PD mouse model.
Zhang Q; Xie H; Ji Z; He R; Xu M; He Y; Huang J; Pan S; Hu Y
Neurosci Lett; 2016 Oct; 632():1-7. PubMed ID: 27542341
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects.
Burks S; Raymick J; Robinson B; Hanig J; Sarkar S
Neurosci Lett; 2019 Jun; 703():86-95. PubMed ID: 30890473
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of MPTP/MPP(+) toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin.
Gao HL; Li C; Nabeka H; Shimokawa T; Saito S; Wang ZY; Cao YM; Matsuda S
Neuroscience; 2013 Apr; 236():373-93. PubMed ID: 23321539
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP
Qi H; Shen D; Jiang C; Wang H; Chang M
Neurosci Lett; 2021 Jan; 741():135493. PubMed ID: 33181233
[TBL] [Abstract][Full Text] [Related]
16. Baicalein protects against MPP
Song Q; Peng S; Zhu X
Neurotoxicology; 2021 Dec; 87():188-194. PubMed ID: 34666128
[TBL] [Abstract][Full Text] [Related]
17. Impaired CBS-H
Yuan YQ; Wang YL; Yuan BS; Yuan X; Hou XO; Bian JS; Liu CF; Hu LF
Brain Behav Immun; 2018 Jan; 67():77-90. PubMed ID: 28774789
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA NEAT1 mediates the toxic of Parkinson's disease induced by MPTP/MPP+ via regulation of gene expression.
Liu Y; Lu Z
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):841-848. PubMed ID: 29575151
[TBL] [Abstract][Full Text] [Related]
19. Poloxamer 188 Attenuates Cerebral Hypoxia/Ischemia Injury in Parallel with Preventing Mitochondrial Membrane Permeabilization and Autophagic Activation.
Luo C; Li Q; Gao Y; Shen X; Ma L; Wu Q; Wang Z; Zhang M; Zhao Z; Chen X; Tao L
J Mol Neurosci; 2015 Aug; 56(4):988-998. PubMed ID: 25966641
[TBL] [Abstract][Full Text] [Related]
20. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]